Back to News
Market Impact: 0.35

See Which Of The Latest 13F Filers Holds AMGN

AMGNBUSENDAQ
Investor Sentiment & PositioningMarket Technicals & FlowsAnalyst Insights
See Which Of The Latest 13F Filers Holds AMGN

Aggregate 13F filings for the 06/30/2025 reporting period indicate that hedge funds significantly increased their collective holdings in Amgen Inc (AMGN), with total shares rising by approximately 10.19% (429,869 shares) from 4,220,375 to 4,650,244 between Q1 and Q2 2025. This substantial accumulation across 507 funds suggests a broader positive sentiment towards AMGN among institutional investors, despite individual fund movements and the inherent limitation of 13F data reflecting only long positions.

Analysis

Analysis of Q2 2025 13F filings for Amgen Inc. (AMGN) reveals a significant divergence between a small sample of funds and the broader institutional landscape. While a select batch of 13 filers showed a net reduction in holdings, with seven funds decreasing positions for an aggregate decline of 4,912 shares, a comprehensive review of 507 funds tells a different story. In aggregate, institutional holdings of AMGN increased by 429,869 shares, a substantial 10.19% jump from 4,220,375 shares in Q1 to 4,650,244 in Q2. This broad-based accumulation, led by major holders like Swedbank AB and Sarasin & Partners LLP, signals a strong positive conviction among a wide swath of institutional investors. Despite the inherent limitation that 13F filings only disclose long positions and exclude potential short-side hedges, the magnitude of the aggregate increase suggests a decidedly bullish institutional sentiment shift towards Amgen during the second quarter.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo

Market Sentiment

Overall Sentiment

strongly positive

Sentiment Score

0.65

Ticker Sentiment

AMGN0.60
BUSE0.00
NDAQ0.00

Key Decisions for Investors

  • Investors should view the 10.19% aggregate increase in hedge fund ownership as a strong bullish signal, indicative of widespread institutional confidence in Amgen's outlook.
  • The significant accumulation by institutional players suggests that investors without a position in AMGN may want to conduct further due diligence on the company's fundamentals.
  • While the overall trend is positive, the net selling within a smaller fund sample and the long-only nature of 13F data warrant supplementing this flow analysis with independent fundamental and technical research before adjusting positions.